<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rapid overview of the care of the pregnant COVID-19 patient with severe or critical respiratory disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rapid overview of the care of the pregnant COVID-19 patient with severe or critical respiratory disease</h1>
<div class="graphic"><div class="figure"><div class="ttl">Rapid overview of the care of the pregnant COVID-19 patient with severe or critical respiratory disease</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Establish disease severity</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>NIH criteria for severe COVID-19 (any of the following): <ul> <li>Sustained respiratory frequency &gt;30 breaths per minute</li> <li>SpO<sub>2</sub> &lt;94% on room air at sea level</li> <li>Ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO<sub>2</sub>/FiO<sub>2</sub>) &lt;300</li> <li>Lung infiltrates &gt;50%</li> </ul> </li> <li>NIH criteria for critical COVID-19 (any of the following): <ul> <li>Respiratory failure (acute respiratory distress syndrome)</li> <li>Septic shock</li> <li>Multiple organ dysfunction</li> </ul> </li> </ul> </td> <td>In pregnancy, the SpO<sub>2</sub> goal is ≥95% on room air at sea level so values &lt;95% trigger intervention for severe disease.</td> </tr> <tr> <td class="subtitle1">Respiratory support</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>Options include: <ul> <li>Low- or high-flow oxygen</li> <li>Prone position</li> <li>Noninvasive positive-pressure ventilation</li> <li>Mechanical ventilation</li> <li>Subsequent interventions include recruitment maneuvers and high PEEP strategies, neuromuscular blocking agents, pulmonary vasodilators, and ECMO as a last resort</li> </ul> </li> </ul> </td> <td> <p>Escalate respiratory support as needed to achieve/maintain SpO<sub>2</sub> ≥95%. By comparison, the typical SpO<sub>2</sub> target in nonpregnant adults with COVID-19 who are receiving supplemental oxygen is 92 to 96%.</p> <p>If the prone position is utilized, pillows/padding are used to ensure no pressure is exerted on the gravid abdomen.</p> Refer to UpToDate content on respiratory care of adult COVID-19 patients for detailed information.</td> </tr> <tr> <td class="subtitle1">Medical management</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>Dexamethasone 6 mg orally or IV once daily for 10 days or until discharge, whichever is shorter.</li> </ul> </td> <td>Dexamethasone is indicated for severely ill patients with COVID-19 who are on supplemental oxygen or ventilatory support. For patients who also meet criteria for use of antenatal corticosteroids to induce fetal maturity, administer dexamethasone 6 mg IV every 12 hours for 4 doses, followed by 6 mg orally or IV once daily for 8 days (10 days total duration), or until discharge, whichever is shorter. Refer to UpToDate content on management of hospitalized adults with COVID-19 for detailed information.</td> </tr> <tr> <td> <ul> <li>Remdesivir</li> </ul> </td> <td>Refer to UpToDate content on management of hospitalized adults with COVID-19 for detailed information.</td> </tr> <tr> <td> <ul> <li>In selected patients, other therapeutics recommended for nonpregnant adults with severe/critical COVID-19 and which may be considered in pregnancy include baricitinib (a JAK inhibitor) and tocilizumab (interleukin-6 antagonist), but there is no or minimal information on fetal risks.</li> </ul> </td> <td> <p>Refer to UpToDate content on management of hospitalized adults with COVID-19 for detailed information.</p> Decisions about use of JAK inhibitors and interleukin-6 antagonists during pregnancy should involve shared decision-making, considering potential maternal benefit and lack of information on fetal risks.</td> </tr> <tr> <td> <ul> <li>VTE prophylaxis: <ul> <li><em>In pregnant patients in whom urgent delivery is likely:</em> prophylactic or intermediate dose unfractionated heparin SUBQ</li> <li><em>In pregnant patients in whom urgent delivery is not likely:</em> prophylactic or intermediate dose enoxaparin SUBQ</li> </ul> </li> </ul> </td> <td>Refer to UpToDate content on prevention of venous thromboembolism in pregnancy for detailed information on dosing.</td> </tr> <tr> <td> <ul> <li>Empiric treatment for influenza or bacterial pneumonia, when indicated.</li> </ul> </td> <td>Refer to UpToDate content on management of hospitalized adults with COVID-19 for detailed information.</td> </tr> <tr> <td class="subtitle1">Pregnancy evaluation</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>Obstetric ultrasound (eg, fetal number, fetal and placental position, gestational age, fetal weight, AFV)</li> <li>GBS culture in patients ≥23 weeks, begin penicillin G pending culture results for standard indications</li> <li>FHR monitoring: <ul> <li>14 to &lt;23 weeks: FHR check daily</li> <li>≥23 weeks: CTG at least daily</li> </ul> </li> </ul> </td> <td> <p>Refer to UpToDate content on prevention of early-onset neonatal GBS for detailed information.</p> The FHR monitor can be used continuously in severely ill hospitalized patients in whom emergency cesarean birth would be performed for a persistent nonreassuring fetal heart rate pattern. An abnormal tracing might also help guide maternal oxygen therapy. In patients with stable SpO<sub>2</sub>, a nonstress test can be performed once or twice daily, as one option.</td> </tr> <tr> <td class="subtitle1">Timing of delivery</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>In general, if SpO<sub>2</sub> ≥95% can be achieved, even if maximum respiratory support is required, the pregnancy can be continued.</li> <li>Decision-making regarding delivery at the patient level depends on many factors, including: <ul> <li>The precise gestational age and plans for neonatal resuscitation.</li> <li>The severity of hypoxemia.</li> <li>The rate of disease progression and response to escalating therapy.</li> <li>Results of tests of fetal well-being.</li> <li>Comorbidities.</li> <li>For pregnancies between 23 and 34 weeks of gestation, whether a course of antenatal corticosteroids has been completed.</li> </ul> </li> </ul> </td> <td>Continue medical and obstetric care as long as the patient is stable or improving. Delivery is not always indicated.</td> </tr> <tr> <td class="subtitle1">Route of delivery</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>In the absence of contraindications to vaginal birth, a trial of labor is attempted if SpO<sub>2</sub> ≥95% can be achieved, even if maximum respiratory support is required.</li> <li>In patients &gt;20 weeks of gestation who have a cardiac arrest, resuscitative cesarean delivery is advised.</li> <li>In patients with a fetal demise, the pregnancy is terminated by induction or by dilation and extraction, if a provider with the appropriate expertise is available.</li> </ul> </td> <td> </td> </tr> <tr> <td class="subtitle1">Management of undelivered, recovered patients</td> <td class="subtitle1">Comments</td> </tr> <tr> <td> <ul> <li>Fetal ultrasound: <ul> <li>At 18 to 20 weeks, if not already performed, and</li> <li>At 32 weeks or 4 weeks after recovery (whichever occurs later in gestation)</li> </ul> </li> <li>Routine prenatal care with delivery for standard obstetric indications.</li> </ul> </td> <td> </td> </tr> </tbody></table></div><div class="graphic_lgnd">A multidisciplinary team including medical specialists, anesthesiology, obstetrics/maternal-fetal medicine, and neonatology needs to be involved in the care of these patients.</div><div class="graphic_footnotes">NIH: National Institutes of Health; 
	SpO<sub>2</sub>: oxygen saturation measurement determined by pulse oximetry; 
	PaO<sub>2</sub>: partial pressure of oxygen in arterial blood; 
	FiO<sub>2</sub>: fraction of inspired oxygen; 
	PEEP: positive end-expiratory pressure; 
	ECMO: extracorporeal membrane oxygenation; 
	IV: intravenous; 
	JAK: Janus kinase; 
	SUBQ: subcutaneous; 
	AFV: amniotic fluid volume; 
	FHR: fetal heart rate; 
	CTG: cardiotocography; 
	GBS: Group B <em>Streptococcus</em>.</div><div id="graphicVersion">Graphic 133124 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
